Dr. Alessandra Granata | Vascular Dementia | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Alessandra Granata : Vascular Dementia

professor at University of Cambridge, United Kingdom

Dr. Alessandra Granata is a distinguished figure in the field of clinical neurosciences, associated with the Heart & Lung Research Institute at the Cambridge Biomedical Campus, Cambridge, UK. Specializing in neurological research, Dr. Granata has made significant contributions to the understanding of disorders affecting the heart and lungs. Her work addresses critical aspects of clinical neurosciences, reflecting a commitment to advancing medical knowledge. With a focus on Papworth Road, Dr. Granata’s contributions at the intersection of neurology and cardiovascular health exemplify her dedication to improving patient outcomes. Her presence at the forefront of medical research marks her as a key contributor to advancements in clinical neurosciences.

 

Professional Profile

Education:

Dr. Alessandra Granata, a distinguished researcher, pursued a Ph.D. from 2000 to 2004 at the MRC Centre for Developmental Neurobiology, King’s College, London. Her groundbreaking work during this period advanced the understanding of developmental neurobiology. Prior to her doctoral studies, Dr. Granata earned a BSc Honours in Biology from the University of Milan, Italy, spanning 1993 to 1999. This foundational education laid the groundwork for her impactful contributions in the field. Dr. Granata’s academic journey reflects a commitment to excellence, positioning her as a key figure in developmental neurobiology, bridging insights from King’s College to her formative years in Milan.

Membership

Dr. Alessandra Granata, an esteemed researcher, serves on the Editorial Board for BMC Cardiovascular Disorders since 2021, showcasing her commitment to advancing cardiovascular research. A member of the International Society for Stem Cell Research (ISSCR) since 2018, Dr. Granata stays at the forefront of stem cell advancements. Her affiliations with the British Society for Cardiovascular Research since 2017 and the British Society for Cell Biology since 2004 underscore her enduring dedication to scientific communities. With a focus on cardiovascular disorders and stem cell research, Dr. Granata’s multifaceted involvement highlights her influential role in shaping advancements and fostering collaboration within these critical scientific domains.

work experience

Dr. Alessandra Granata is a distinguished researcher known for her impactful contributions to neuroscience. Currently an MRF Fellow for the Medical Research Foundation Stroke in Young Adults, she focuses on genetic forms of stroke and vascular dementia using human stem cell-based models. As a Senior Research Associate at the University of Cambridge, Dr. Granata leads a group dedicated to developing stem cell-derived models for genetic stroke and cerebral small vessel disease. Her prior roles include postdoctoral research at the Anne McLaren Laboratory, focusing on Marfan Syndrome, and investigating DYT1 Dystonia at the Royal Free & University College Medical School. Throughout her career, Dr. Granata’s work reflects a commitment to advancing our understanding of neurological disorders.

Publications top noted:

A novel human iPSC model of COL4A1/A2 small vessel disease unveils a key pathogenic role of matrix metalloproteinases

https://pubmed.ncbi.nlm.nih.gov/35733040/Functional genomics in stroke: current and future applications of iPSCs and gene editing to dissect the function of risk variants

A phenotypic screen of Marfan syndrome iPSC-derived vascular smooth muscle cells uncovers GSK3β as a new target

A multi-disciplinary commentary on preclinical research to investigate vascular contributions to dementia

The Histone Deacetylase 9 Stroke-Risk Variant Promotes Apoptosis and Inflammation in a Human iPSC-Derived Smooth Muscle Cells Model

Global proteomic analysis of extracellular matrix in mouse and human brain highlights relevance to cerebrovascular disease

 

 

 

 

Dr. s. A. Marzouk | Impinging Jet

Published on by Cardiology and Cardiovascular Medicine

Dr. s. A. Marzouk : Leading Researcher in Impinging Jet

professor at kafrelsheikh University, Egypt

Congratulations, Dr. s. A. Marzouk on winning the esteemed Best Researcher Award from pencis! Your dedication, innovative research, and scholarly contributions have truly made a significant impact in your field. Your commitment to advancing knowledge and pushing the boundaries of research is commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. Well done!

Dr. S. A. Marzouk is a distinguished Mechanical Engineer holding a Ph.D. in Mechanical Engineering from Kafrelsheikh University, Egypt, with a stellar GPA of 3.9. His doctoral thesis, “Performance study of helically tube heat exchanger with novel configurations,” showcases his expertise in innovative heat exchanger designs. Prior to his Ph.D., he earned a Master’s degree with a GPA of 3.66, focusing on “Thermo-hydraulic Performance Enhancement of Shell-and-tube Heat Exchanger.” Dr. Marzouk’s academic journey began with a Bachelor’s in Mechanical Engineering (Power Mechanics) with honors, achieving an outstanding 91%. His notable project involved the design of a 50 TR water chiller for air cooling in buildings.

Professional Profile

Education:

Dr. S. A. Marzouk, a Mechanical Engineering scholar at Kafrelsheikh University, Egypt, has showcased academic excellence throughout his journey. Currently pursuing a Ph.D. with a remarkable 3.9 GPA, his research focuses on the “Performance study of helically tube heat exchanger with novel configurations.” Prior accomplishments include a Master’s in Mechanical Engineering with a 3.66 GPA, delving into the “Thermo-hydraulic Performance Enhancement of Shell-and-tube Heat Exchanger.” His Bachelor’s, earned with honors, featured a notable project: the “Design of a 50 TR water chiller for air cooling of a building.” Dr. Marzouk’s academic trajectory reflects a passion for innovative mechanical solutions and research 🌟

Courses

Dr. S. A. Marzouk’s extensive academic journey has equipped him with a profound understanding of mechanical engineering disciplines. His expertise spans Heat Transfer, Mechanics (Static and Dynamics), Applied Mechanics, Computational Fluid Dynamics, Thermodynamics, Fluid Mechanics, Internal Combustion Engines I and II, Measurements, Hydraulic Machines, Industrial Safety, Engineering Drawing and Projection, and Machine Design. 🚀 These comprehensive areas of study reflect a diverse skill set, combining theoretical knowledge with practical applications. Dr. Marzouk’s commitment to mastering these facets of mechanical engineering underscores his dedication to contributing valuable insights and solutions to the field.

work experience

Dr. Amir Sohai embodies a diverse and impactful professional journey, currently immersed in a Complex Surgical Oncology Fellowship at the University of New Mexico since August 2023. Prior, he completed a General Surgery Residency at New York University Langone Health and the New York University Long Island School of Medicine. Dr. [Name] began his surgical career with a General Surgery Internship at Howard University Hospital in Washington, DC, and engaged in healthcare improvement initiatives in Pakistan. Beyond medicine, he co-founded the Humanity Initiative, fostering community health, and has contributed as a freelance writer, addressing sociopolitical issues. His multifaceted contributions reflect a dedication to both medical excellence and societal well-being. 🌟👨‍⚕️

Personal Experience

Dr. S. A. Marzouk is proficient in a diverse array of engineering tools and software, including SOLIDWORKS, AUTOCAD, ENDNOTE, MATLAB, GRAPHER, and Microsoft applications. His expertise extends to specialized platforms such as ANSYS FLUENT and ASPEN PLUS, incorporating ASPEN EXCHANGER DESIGN AND RATING. 🛠️ His ANSYS projects encompass the analysis of Shell and Tube Heat Exchangers, Plate Heat Exchangers, and the solidification process of water inside a bud. Notably, his ASPEN PLUS and ASPEN EXCHANGER DESIGN AND RATING projects involve critical contributions to the South Refineries Company (Iraq), focusing on Crude Oil Distillation and Ammonia Units, as well as the State Company for Petrochemical Industries in Iraq, specifically the Low-Density Polyethylene (LDPE) plant. 🌐

Publications top noted:

Experimental study on air impinging jet for effective cooling of multiple protruding heat sources

Enhancement of heat transfer in a vertical shell and tube heat exchanger using air injection and new baffles: Experimental and numerical approach

Evaluating the effects of bifurcation angle on the performance of a novel heat exchanger based on contractual theory

Numerical study of heat transfer, exergy efficiency, and friction factor with nanofluids in a plate heat exchanger

A comprehensive review of methods of heat transfer enhancement in shell and tube heat exchangers

Study of heat transfer and pressure drop for novel configurations of helical tube heat exchanger: a numerical and experimental approach

Experimental and numerical investigation of a novel fractal tube configuration in helically tube heat exchanger

Dr. Amir Sohail | Health Services

Published on by Cardiology and Cardiovascular Medicine

Dr. Amir Sohail: Leading Researcher in Health Services

professor at  University of New Mexico, USA

Congratulations, Dr. Amir Sohail on winning the esteemed Young Scientist Award from pencis! Your dedication, innovative research, and scholarly contributions have truly made a significant impact in your field. Your commitment to advancing knowledge and pushing the boundaries of research is commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. Well done!

Dr. Amir Sohail, based in the USA, is a versatile professional who earned his MBBS (Bachelor of Medicine, Bachelor of Surgery) from Aga Khan University – Medical College in 2015. Driven by a passion for global health, he pursued a Master of Science in Global Health Science at the University of Oxford from October 2016 to September 2017. During his time at Oxford, Dr. Sohail received the prestigious fully-funded Oxford Weidenfeld and Hoffmann Scholarship. Currently associated with the University of New Mexico, he blends medical expertise with a global health perspective, contributing significantly to healthcare and research endeavors.

Professional Profile

Education:

Dr. Amir Sohail’s academic journey reflects a commitment to excellence and a fusion of medical expertise with global health perspectives. From October 2010 to September 2015, he pursued his MBBS at Aga Khan University – Medical College, shaping his foundation in medicine. Subsequently, from October 2016 to September 2017, Dr. Sohail ventured into global health, obtaining a Master of Science in Global Health Science from the University of Oxford. His academic pursuits were underscored by the prestigious Oxford Weidenfeld and Hoffmann Scholarship, fully funding his studies at Exeter College. Today, Dr. Sohail, with a diverse skill set, contributes to the healthcare landscape, combining local and global perspectives. 🌐👨‍⚕️

Professional Exams

Dr. Amir Sohail showcases a stellar academic and professional trajectory, evident in his impressive performance on various examinations. Recently, in July 2023, he successfully passed the American Board of Surgery Qualifying Exam. Throughout his residency, he consistently excelled in the American Board of Surgery In-Training Exam (ABSITE), with percentiles ranging from 74th to 93rd. Dr. [Name] also triumphed in the United States Medical Licensing Examinations, achieving a notable score of 260 on Step 1, 253 on Step 2 Clinical Knowledge, and passing Step 3 with a score of 225. His commitment to excellence and continuous learning is reflected in this remarkable academic journey. 🌟👨‍⚕️

 

work experience

Dr. Amir Sohai embodies a diverse and impactful professional journey, currently immersed in a Complex Surgical Oncology Fellowship at the University of New Mexico since August 2023. Prior, he completed a General Surgery Residency at New York University Langone Health and the New York University Long Island School of Medicine. Dr. [Name] began his surgical career with a General Surgery Internship at Howard University Hospital in Washington, DC, and engaged in healthcare improvement initiatives in Pakistan. Beyond medicine, he co-founded the Humanity Initiative, fostering community health, and has contributed as a freelance writer, addressing sociopolitical issues. His multifaceted contributions reflect a dedication to both medical excellence and societal well-being. 🌟👨‍⚕️

Research Experience

As a Global Justice Fellow at Yale University since November 2023, Dr. Amir Sohai is delving into market-based solutions for global health challenges under the guidance of Dr. Thomas Pogge. Concurrently, as a Surgical Outcomes Club Michael Zinner Health Services Research Fellow, he contributes to projects on end-of-life care and healthcare provider bias at MD Anderson Cancer Center under Dr. Rebecca Snyder’s mentorship. Dr. Amir Sohai has significantly contributed to global health research as a co-investigator for the Covid Surg Cohort Study, published in The Lancet, and delved into mental health among hepatitis B patients in Pakistan. His impactful research journey includes a research placement at the Big Data Institute, University of Oxford, showcasing a commitment to advancing healthcare through rigorous investigation and global perspectives. 🌍👨‍⚕️

 

Publications top noted:

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Cited By :   1727 Year : 2020

Bullous scabies: a case report and review of the literature

Cited By :  28  Year : 2015

Tobacco control laws in Pakistan and their implementation: A pilot study in Karachi

Cited By :  26  Year : 2016

Comparison of artificial intelligence with other interventions to improve adenoma detection rate for colonoscopy: a network meta-analysis

Cited By :  21  Year : 2022

Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis

Cited By : 18  Year : 2021

Cardiac tamponade in COVID‐19 patients: Management and outcomes

Cited By : 16  Year : 2020

Prior bariatric surgery is associated with a reduced risk of poor outcomes in COVID-19: propensity matched analysis of a large multi-institutional research network

Cited By : 11  Year : 2022

 

 

Prof Dr. Taira q Kajisa | Diabetology

Published on by Cardiology and Cardiovascular Medicine

Prof Dr. Taira q Kajisa : Leading Researcher in Diabetology

professor at  Toyo University, Japan

Congratulations, Dr. Taira q Kajisa, on winning the esteemed Best Researcher Award from pencis! Your dedication, innovative research, and scholarly contributions have truly made a significant impact in your field. Your commitment to advancing knowledge and pushing the boundaries of research is commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. Well done!

Dr. Taira Q Kajisa, a distinguished Ph.D. graduate in Agriculture and Biochemistry from the University of Tokyo (March 2009), conducted groundbreaking research on enzymatic degradation of cellulose by brown rot fungi. Serving as Chief Science Officer at PROVIGATE Inc., Tokyo, from March 2015 to March 2019, he transitioned into academia, becoming a Lecturer at Tokushima University (April 2019 – March 2021) and currently an Associate Professor at Toyo University since April 2021. His impactful contributions extend to project research at the University of Tokyo and research roles at Mitsubishi Rayon Corp. Dr. Kajisa’s pioneering work has led to the launch of three successful start-up companies.

Professional Profile

Education:

Dr. Taira Q Kajisa earned a Ph.D. in Agriculture with a specialization in Biochemistry from the University of Tokyo on March 31, 2009 🎓. His doctoral research, completed on March 23, 2009, delved into the molecular biological analysis of restriction factors influencing the enzymatic degradation of cellulose by brown rot fungi within the Agricultural and Life Science department at the University of Tokyo 🌱. This innovative work not only contributed to the academic realm but also showcased his commitment to advancing our understanding of biological processes with potential applications in agriculture and beyond 🚀.

Previous work experience

Dr. Taira Q Kajisa  has crafted a diverse career in academia and industry, showcasing expertise across various roles. As a Lecturer at Tokushima University’s Institute of Post-LED Photonics from April 2019 to March 2021, he contributed to the institution’s academic environment 🎓. Serving as Chief Science Officer at PROVIGATE Inc. in Tokyo from March 2015 to March 2019, Dr. [Name] played a pivotal role in steering scientific endeavors within the corporate realm 🚀. His academic journey includes a role as a Project Researcher in Material Engineering at the University of Tokyo and a significant research tenure at Yokohama Advanced Technology Research Laboratories, Mitsubishi Rayon Corp. Throughout, Dr. [Name] has demonstrated a commitment to cutting-edge research and innovation.

Current position

Dr. Taira Q Kajisa, a distinguished academic, assumed the role of Associate Professor at Toyo University, marking the beginning of his impactful tenure on April 1, 2021, and continuing to contribute actively to date 📚. With a wealth of experience in biochemistry and agriculture, Dr. Kajisa brings a robust background, shaping the academic landscape at Toyo University. His commitment to education and research is evident in his role, where he undoubtedly enriches the academic environment, fostering a culture of innovation and knowledge dissemination. Dr. Kajisa’s current position reflects his dedication to advancing scholarly pursuits and nurturing the next generation of professionals in his field.

Publications top noted:

Bioanalytical method based on extended-gate field-effect transistor modified by self-assembled monolayer

Biocompatible Poly(catecholamine)-Film Electrode for Potentiometric Cell Sensing

Catecholamine Detection Using a Functionalized Poly(l-dopa)-Coated Gate Field-Effect Transistor

Well-designed dopamine-imprinted polymer interface for selective and quantitative dopamine detection among catecholamines using a potentiometric biosensor

Dynamic electrical behaviour of a thermoresponsive polymer in well-defined poly(N-isopropylacrylamide)-grafted semiconductor devices

Molecularly imprinted polymer-based FET biosensor for oligosaccharides sensing to target cancer cells

The genes encoding glycoside hydrolase family 6 and 7 cellulases from the brown-rot fungus Coniophora puteana

Purification, identification and molecular cloning of glycoside hydrolase family 15 glucoamylase from the brown-rot basidiomycete Fomitopsis palustris

Dr. Zakir Khan | Myeloid cell function

Published on by Cardiology and Cardiovascular Medicine

Dr. Zakir Khan : Leading Researcher in Myeloid cell function

professor at  Cedars-Sinai Medical Center, United States

Congratulations, Dr. Zakir Khan, on winning the esteemed Best Researcher Award from pencis! Your dedication, innovative research, and scholarly contributions have truly made a significant impact in your field. Your commitment to advancing knowledge and pushing the boundaries of research is commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. Well done!

Professional Profile

Google Scholar Profile

Education:

  • Ph.D. (2009) : Biotechnology (Cancer Biology), Bundelkhand University Jhansi, India
  • M.Sc. (2001) : Biochemistry, Jiwaji University Gwalior, India.
  • B.Sc. (1999) : Biology Major (Zoology, Botany, Chemistry), Jiwaji University Gwalior, India

Positions and Scientific Appoitments

  • 2019 – Assistant Professor of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA
  • 2019 – Assistant Professor of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA
  • 2019 – Research Scientist I, Cedars-Sinai Medical Center, Los Angeles, CA
  • 2022 – Member, American Society of Hematology (ASH)
  • 2018 – Member, American Heart Association (AHA)
  • 2018 – 2019 Member, American Society for Biochemistry and Molecular Biology (ASBMB)
  • 2015 – 2018 Project Scientist, Cedars-Sinai Medical Center, Los Angeles, CA
  • 2013 – 2014 Member, The French Society for Biochemistry and Molecular Biology (SFBBM)
  • 2013 – 2014 Postdoc, Institute Curie, Paris, France

Teaching Activities:

  • 2019 – Cedars-Sinai Medical Center; 5% Effort Courses: Immunology, Biochemistry and Cardiovascular Physiology
  • 2003 – 2007 Madhav Institute of Technology & Science (MITS) Gwalior, India; 5% Effort Courses: Biochemistry and Molecular Biology – BS and MS level.
  • 2002 – 2003 GICTS Group of Colleges, Gwalior, India; 90% Effort Courses: Biochemistry, Enzymology, and Molecular Biology – BS and MS level.
  • 2001 – 2002 Subhash Chandra Bose College, Gwalior, India; 90% Effort Courses: Biochemistry, Enzymology, and Molecular Biology – BS and MS level.

Honors and Awards:

  • 2022 – Board Member, “Cancer Advances”, ISSN 2815-7125
  • 2022 Advisory committee member, 2nd Int-BIONANO Conference 2022, Amity Uni., Gwalior
  • 2021 Cedars-Sinai Academic Pathology Minigrant Award (COVID-19 Research) 2020 Cedars-Sinai Academic Pathology Minigrant Award (Cancer Research)
  • 2019 Career Development Award – American Heart Association (3 years grant)
  •  2019 – 2021 Board Member, “Cellular & Molecular Biology Letters”, ISSN 1689-1392
  • 2018 – 2020 Research consultant (honorary), Innoscience Research, Selangor, Malaysia
  • 2016 – Editorial Board Member, “Journal of Solid Tumors”, ISSN 1925-4067
  • 2013 Young Investigator Award – Institute Curie (1 year fellowship)
  • 2012 – 2014 Guest Editor, Special issue “Current Medicinal Chemistry”, ISSN: 0929-8673

Peer-Reviewed Papers:

  •  Total Journal Impact Factor : 498
  • Total Citations : 3278
  •  h-index : 26 i10
  •  index : 40

Publications top noted:

Nutritional and therapeutic potential of Spirulina ( cited by- 672- year -2005)

Structural, functional and therapeutic biology of survivin

Angiotensin-converting enzyme in innate and adaptive immunity

Biology of Cox-2: an application in cancer therapeutics

Slow CCL2-dependent translocation of biopersistent particles from muscle to brain

Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma

Oncoapoptotic signaling and deregulated target genes in cancers: special reference to oral cancer

Cardiac troponins I and T: molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction

Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings

 

Prof. Yu-Cheng Hsiao | Biomedical Engineering

Published on by Cardiology and Cardiovascular Medicine

Prof. Yu-Cheng Hsiao : Leading Researcher in Biomedical Engineering

professor at  Taipei Medical University, Taiwan

Congratulations, Prof. Yu-Cheng Hsiao, on winning the esteemed Best Researcher Award from pencis! Your dedication, innovative research, and scholarly contributions have truly made a significant impact in your field. Your commitment to advancing knowledge and pushing the boundaries of research is commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. Well done!

Professional Profiles:

Scopus Profile

Google Scholar Profile

Education:

  • National Chiao Tung University, College of Photonics 2015.2–2017.12, Taiwan ,  PhD in Photonics Ranking: 1 st in the college
  • National Taiwan University, Graduate Institute of Physics 2011.9–2013.8, Taiwan,  MS in Applied Physics Thesis ranking: 1st in the institute
  • Chung Yuan Christian University, Department of Physics 2007.9–2011.7, Taiwan , BS in Physics, Photonics and Materials Science Program Ranking: 1st in the department

Specialization:

Optics, photonics, biophotonics, biomaterials, new energy materials, industrial design, AI, 3D printing, quantum computing, entrepreneurship education

Experiences :

  • Founder of uMeal Co., LTD. Founder of Visioner Tech Co., LTD. 2022-now, Taiwan
  • Stanford Byers Center for Bodesign Global Faculty, Stanford University 2021-now, USA
  • CEO of Medical 3D Printing Center, Taipei Medical University 2022-2023, Taiwan
  • Associate Professor, National Defense Medical Center 2022-now, Taiwan
  • Associate Professor in Graduate Institute of Biomedical Optomechatronics, College of Biomedical Engineering, Taipei Medical University 2021-now, Taiwan
  • Deputy CEO of Biodesign Center, Taipei Medical University 2021-2023, Taiwan
  • Director of Innovation Entrepreneurship Education Center, Taiwan 2020-2023, Taiwan
  • Founder and CEO of Arker Mask Co., LTD. 2018-2020, Taiwan
  • LEAP program researcher in UC Berkeley 2018, USA
  • Taiwan Semiconductor Manufacturing Co., Ltd. Manufacturing Technology Center 2017, Taiwan

Honors and Awards:

WORLD’s TOP 2% SCIENTISTS 2021-2022 (by Stanford University)

SID Creativity Award 2023

‘‘Champion,’’Asia Innovation and Entrepreneurship Development Competition 2022

Research Excellence Award Taipei Medical University 2022

Young Scholars Research Award Taipei Medical University 2022

‘‘Gold award,’’The China International College Students Internet + Innovation and Entrepreneurship Competition, China (2022).

The 5th Presidential Innovation Award Individual Group 2022

International Top Journal Paper Award Taipei Medical University 2022

Excellent mentor at Taipei Medical University 2022

‘‘Entrepreneurial Star,’’ Taiwan 2022

‘‘National Innovation Award,’’ Taiwan (2020-2022).

‘‘Future Technology Award,’’ Ministry of Science & Technology, Taiwan (2020-2022).

‘‘Vebleo Fellow,’’ Taiwan (2020-2022).

Outstanding teaching faculty at Taipei Medical University 2021

‘‘Young Scholar Fellowship, Einstein Award,’’ Ministry of Science & Technology, Taiwan (2019).

‘‘Gold award,’’ The China International College Students Internet + Innovation and Entrepreneurship Competition, China (2018).

‘‘Finalist,’’ Global Entrepreneurship Congress, USA (2018).

‘‘Silver award,’’ Guangdong College Students Startup Competition, China (2017).

‘‘Honor for university,’’ NCTU, Taiwan (2015–2017).

‘‘Star of science,’’ Hsinchu Science Park, Taiwan (2017).

‘‘First prize,’’ Longterm Startup Competition, Taiwan (2016).

‘‘First prize,’’Mainland China, Hong Kong, Macau, and Taiwan Joint Startup Competition, Asia (2016).

‘‘Practical award,’’ CPC New Energy Creative Competition, CPC Taiwan (2016).

‘‘SPIE Optics and Photonics Education Scholarships,’’ United States (2016).

‘‘Research excellence award, ’’SPIE Newport, United States (2015).

‘‘Research excellence award, ’’ Spintech technology thesis awards, Taiwan (2015).

‘‘The best research award,’’ R.O.C. Taiwan Liquid Crystal Society, Taiwan (2015).

‘‘Rotary International Clubs Scholarship,’’ Taiwan Rotary Clubs Association, Taiwan (2015).

‘‘Wu Mo-Ching Memorial Scholarship,’’ NCTU, Taiwan (2014–2016).

‘‘Humanism award,’’ TECO Green Tech International Contest, Taiwan (2015).

‘‘The best oral award,’’ The 4th Symposium on Liquid Crystal Photonics, China (2015).

‘‘The outstanding academic contributed award,’’ NCTU, Taiwan (2014–2016).

‘‘Champion of physics in paper competition,’’ Physical Society of Republic of China, (2013).

‘‘Dean’s award,’’ National Taiwan University, Taiwan (2013).

‘‘The Phi Tau Phi Scholastic Honorary Membership,’’ Chung Yuan Christian University, Taiwan (2011).

Patents:

  • Yu-Cheng Hsiao, “Synthesis of High Electrostatically Charged Polymers,” Taiwan Patent Application.
  • Yu-Cheng Hsiao, “Novel Mask Production,” Taiwan Patent No. 10541191360.
  • Yu-Cheng Hsiao, “Improved Mask Structure,” Taiwan Patent No. 106208939.
  • Yu-Cheng Hsiao, “Nursing Education Robot,” Taiwan Patent No. M636576.
  • Yu-Cheng Hsiao, “Improved Mask Structure,” Taiwan Patent No. M554001.
  • Y.-C. Hsiao, “New Mask Design,” US Patent Pending.
  • Y.-C. Hsiao, “Ionized Polymer Synthesis,” US Patent Pending.
  • Technology transfer of 2021 nano photothermal materials (Medical Engineering Institute) to Hsuan-Chen Co., Ltd

Projects

► Ministry of Science and Technology Talent Training for Stanford Medical Equipment Product Design MOST 107-2218-E-038-007 NTD 3,600,000 2022 (Principal Investigator)

► Taipei Medical University and National Taipei University of Technology Joint Research and Development Center Grant Project Multiple Fluid Microscopy Imaging Technology Group for Diagnosis and Image Analysis of Complex Joint Fluids and Cerebrospinal Fluids 111TN12 NTD 1000000 2022-2023 (Principal Investigator)

► Metal Industries Research & Development Centre Assistance Program for the Development of Precision Medical Device Industry Talent in Taipei and New Taipei MOST 111-2221-E-038-012- NTD 1000000 2022-2023 (Co-Principal Investigator)

► Ministry of Science and Technology Research on Artificial Intelligence Sensing and Biomedical Optoelectronic Effects on the Regulation of Adipose Stem Cell Growth by Specific Wavelength Laser Light MOST 111-2221-E-038-012- NTD 2,595,322 2022-2023 (Co-Principal Investigator)

► Ministry of Science and Technology Innovative Liquid Crystal Induction Components for Biomedical Cancer Immunotherapy and Environmental Hazard Detection and Database Construction MOST 110-2636-E-038-005 NTD 25,000,000 2019-2022 (Principal Investigator)

► Ministry of Education “Translational Innovation Research Project” for Higher Education Integration of Advanced Biomedical Materials, Nano  photonics and Deep Learning Innovative Technologies for Precision Treatment, Detection and Care of Diabetes Wounds 110-research-R-0010 NTD 1,000,000 2022/01-2022/12 (Principal Investigator)

► Ministry of Education Interdisciplinary Talent Cultivation Program for Biomedical Industry and New Agriculture 109-research-R-0009 NTD 8,200,000 2018-2022 (Co-Principal Investigator)

► Ministry of Education Interdisciplinary Talent Cultivation Program for Precision Health Industry 110-research-R-0008 NTD 8,000,000 2022-2025 (Co-Principal Investigator)

► Ministry of Science and Technology Talent Training for Stanford Medical Equipment Product Design MOST 107-2218-E-038-007 NTD 3,600,000 2021 (Co-Principal Investigator)

► Ministry of Education Interdisciplinary Biomedical Innovation Research and Women’s Talent Cultivation Program 111111 NTD 12,800,000 2021-2024 (Co-Principal Investigator)

► Taipei Medical University Newly Hired Faculty Research Grant TMU106-AE1-B49 NTD 1,000,000 2018-2019 (Principal Investigator)

► Taipei Medical University – Affiliated Hospital Special Research Project Real-time Sensing of Artificial Intelligence Liquid Crystal Sensors in Urinary Catheterization Project 111TMU-TMUH-01-3 NTD 1,000,000 2022/05-2023/04 (Co-Principal Investigator)

► Wan Fang Hospital Paper-Based Liquid Crystal Microchannel Biomedical Sensor 109TMU-WFH-14 NTD 1,000,000 2020/05-2021/04 (Principal Investigator)

► Wan Fang Hospital Acute Myocardial Infarction Biomedical Sensor 110TMU-WFH-23 NTD 1,000,000 2021/05-2/2022/04 (Principal Investigator)

► Wan Fang Hospital [Innovative Medical] Adaptive Electrochemical and Optoelectronic Biosensing Technology Using Novel Lyotropic Liquid Crystal Sensing Medium 111TMU-WFH-23 NTD 1,000,000 2022/05-2/2023/04 (Principal Investigator)

► Sinyi Hospital AI-Enabled Heart Failure Liquid Crystal Optoelectronic Sensing Technology 111TMU-WFH-23 NTD 1,000,000 2022/05-2/2023/04 (Principal Investigator)

 

Publications & Contributions:

  • Fast-switching bistable cholesteric intensity modulator
  • Electro-optical device based on photonic structure with a dual-frequency cholesteric liquid crystal
  • Simple mono-halogenated perylene diimides as non-fullerene electron transporting materials in inverted perovskite solar cells with ZnO nanoparticle cathode buffer layers
  • Electrochemical photocatalytic degradation of dye solution with a TiO2-coated stainless steel electrode prepared by electrophoretic deposition
  • Multichannel photonic devices based on tristable polymer-stabilized cholesteric textures
  • Solution-processed conductive interconnecting layer for highly-efficient and long-term stable monolithic perovskite tandem solar cells
  • Highly sensitive color-indicating and quantitative biosensor based on cholesteric liquid crystal
  • Novel In Situ Synthesis of Freestanding Carbonized ZIF67/Polymer Nanofiber Electrodes for Supercapacitors via Electrospinning and Pyrolysis Techniques
  • High UV-Vis-NIR Light-Induced Antibacterial Activity by Heterostructured TiO2-FeS2 Nanocomposites
  • Unveiling the antibacterial mechanism of gold nanoclusters via in situ transmission electron microscopy
  • Spectral modulation of a bistable liquid-crystal photonic structure by the polarization effect

 

Introduction of Wellness Champion Award

Published on by Cardiology and Cardiovascular Medicine

Introduction of Wellness Champion Award

Step into a world where commitment to wellness is celebrated and honored with the Wellness Champion Award. This prestigious accolade recognizes individuals who have demonstrated exceptional dedication to fostering wellness in their communities. Join us in applauding the champions who inspire and lead the way towards a healthier and happier world.

Award Eligibility: The Wellness Champion Award is open to individuals across various fields who have made remarkable contributions to promoting and enhancing wellness. Eligible candidates include healthcare professionals, educators, community leaders, and advocates with a minimum of 5 years of active engagement in wellness initiatives.

Age Limits and Qualifications: There are no age restrictions for this award. Qualified candidates should possess relevant qualifications and a proven track record of impactful work in wellness. This includes demonstrating leadership, innovation, and a commitment to the well-being of individuals and communities.

Publications and Requirements: Applicants are encouraged to submit a portfolio highlighting their contributions to wellness. While publications are not mandatory, any relevant articles, blogs, or other materials showcasing the candidate’s impact on wellness are welcomed.

Evaluation Criteria: Submissions will be evaluated based on the candidate’s demonstrated commitment to promoting wellness. Criteria include leadership in wellness initiatives, innovation in promoting healthy living, and measurable positive impact on the well-being of individuals or communities.

Submission Guidelines: Detailed submission guidelines can be found in the official application package. All applications must be submitted electronically, adhering to the provided format and including the necessary supporting documents.

Recognition: The recipient of the Wellness Champion Award will receive a prestigious trophy, a certificate of recognition, and the opportunity to share their insights and experiences at a dedicated wellness forum or event.

Community Impact: This award not only acknowledges individual achievement but also celebrates the broader impact on communities. Awardees are expected to actively contribute to knowledge dissemination, mentorship, and collaborative initiatives within the field of wellness.

Biography, Abstract, and Supporting Files: Applicants should provide a concise biography highlighting their commitment to wellness. An abstract of their most significant wellness initiatives and relevant supporting files, such as testimonials or project outcomes, should be included for comprehensive evaluation.

Introduction of Cardiovascular Excellence in Industry Award

Published on by Cardiology and Cardiovascular Medicine

Introduction of Cardiovascular Excellence in Industry Award

Welcome to the Cardiovascular Excellence in Industry Award, a distinguished recognition celebrating leaders in the industry who have demonstrated excellence in advancing cardiovascular health. This award honors individuals and organizations that have made significant contributions to shaping the future of cardiovascular well-being within the industry.

Eligibility: The Cardiovascular Excellence in Industry Award is open to individuals and organizations actively contributing to the advancement of cardiovascular health within the industry. There are no age limits, and eligibility is based on demonstrated excellence in areas such as leadership, innovation, and community impact.

Qualifications: Candidates must showcase a strong background in the industry, demonstrating a commitment to advancing cardiovascular health through innovative solutions. Qualifications may include professional experience, business leadership, and a track record of impactful contributions to cardiovascular well-being.

Publications and Requirements: Applicants are encouraged to submit relevant publications that highlight their expertise in advancing cardiovascular health within the industry. Requirements may include industry reports, case studies, or other publications that demonstrate the candidate’s significant contributions to the field.

Evaluation Criteria: Submissions will be evaluated based on leadership qualities, impact on cardiovascular health, and the potential to advance the understanding and application of cardiovascular industry practices. A distinguished panel of experts will carefully assess each submission against these criteria.

Submission Guidelines: To be considered for the Cardiovascular Excellence in Industry Award, applicants must adhere to the submission guidelines outlined on our official website. Submissions should include a detailed biography, an abstract of the industry initiatives, and supporting files showcasing the impact of the candidate’s contributions.

Recognition: Recipients of the Cardiovascular Excellence in Industry Award will receive public recognition for their outstanding achievements in advancing cardiovascular health within the industry. This includes features in industry publications, acknowledgment at relevant events, and the opportunity to share insights with the community.

Community Impact: The Cardiovascular Excellence in Industry Award emphasizes the importance of community impact. Successful candidates will demonstrate how their industry initiatives have positively affected individuals and communities, contributing to the overall well-being of society.

Biography: Candidates are required to submit a comprehensive biography, highlighting their journey, achievements, and dedication to advancing cardiovascular health within the industry. This allows the selection committee to gain a deeper understanding of the candidate’s background and contributions.

Abstract and Supporting Files: Applicants should provide a concise abstract summarizing their industry initiatives and their significance in advancing cardiovascular health. Supporting files, such as industry reports, presentations, or visual materials, should be included to provide a comprehensive overview of the candidate’s contributions.

Introduction of Health Advocate of the Year Award

Published on by Cardiology and Cardiovascular Medicine

Introduction of Health Advocate of the Year Award

Welcome to the Health Advocate of the Year Award, a distinguished recognition celebrating individuals who have shown exceptional dedication to healthcare advocacy. This award honors advocates making a significant impact in improving healthcare outcomes and championing positive change in the healthcare landscape.

Eligibility: The Health Advocate of the Year Award is open to individuals of all ages who have demonstrated outstanding dedication and achievements in healthcare advocacy. Eligibility is based on a proven record of advocacy excellence, significant contributions to healthcare, and a commitment to fostering positive change.

Qualifications: Candidates must possess a strong background in healthcare advocacy, showcasing a commitment to improving healthcare outcomes for individuals and communities. Qualifications may include advocacy achievements, professional experience, and a track record of impactful contributions in the healthcare sector.

Publications and Requirements: Applicants are encouraged to submit relevant publications or documentation that highlight their advocacy efforts. Requirements may include articles, reports, or other publications that demonstrate the candidate’s significant contributions to healthcare advocacy.

Evaluation Criteria: Submissions will be evaluated based on the impact of the candidate’s advocacy efforts, dedication to positive change, and the potential for lasting improvements in healthcare outcomes. A distinguished panel of experts will carefully assess each submission against these criteria.

Submission Guidelines: To be considered for the Health Advocate of the Year Award, applicants must adhere to the submission guidelines outlined on our official website. Submissions should include a detailed biography, an abstract of the candidate’s advocacy initiatives, and supporting files showcasing the impact of their contributions.

Recognition: Recipients of the Health Advocate of the Year Award will receive public recognition for their outstanding achievements in healthcare advocacy. This includes features in healthcare publications, acknowledgment at relevant events, and the opportunity to share insights with the community.

Community Impact: The Health Advocate of the Year Award emphasizes the importance of community impact. Successful candidates will demonstrate how their advocacy initiatives have positively affected individuals and communities, contributing to the overall well-being of society.

Biography: Candidates are required to submit a comprehensive biography, highlighting their journey, achievements, and dedication to healthcare advocacy. This allows the selection committee to gain a deeper understanding of the candidate’s background and contributions.

Abstract and Supporting Files: Applicants should provide a concise abstract summarizing their advocacy initiatives and their significance in improving healthcare outcomes. Supporting files, such as articles, reports, or visual materials, should be included to provide a comprehensive overview of the candidate’s advocacy impact.

Introduction of Leadership in Cardiovascular Medicine Award

Published on by Cardiology and Cardiovascular Medicine

Introduction of Leadership in Cardiovascular Medicine Award

Welcome to the Leadership in Cardiovascular Medicine Award, a prestigious accolade recognizing exemplary leaders in the field of cardiovascular health. This award is dedicated to honoring individuals whose leadership has made a lasting impact on advancing cardiovascular medicine, contributing to the overall well-being of individuals and communities.

Eligibility: The Leadership in Cardiovascular Medicine Award is open to individuals who have demonstrated exceptional leadership in the field of cardiovascular medicine. There are no age limits, and eligibility is based on a proven record of leadership excellence, significant contributions to the advancement of cardiovascular medicine, and a commitment to improving patient outcomes.

Qualifications: Candidates must possess a strong background in cardiovascular medicine, showcasing a commitment to leadership and excellence. Qualifications may include medical achievements, professional experience, and a track record of impactful contributions that have influenced the field.

Publications and Requirements: Applicants are encouraged to submit relevant publications that highlight their expertise in cardiovascular medicine. Requirements may include research papers, articles, or other publications that demonstrate the candidate’s significant contributions to the field.

Evaluation Criteria: Submissions will be evaluated based on leadership qualities, impact on cardiovascular medicine, and the potential to inspire positive change. A distinguished panel of experts will carefully assess each submission against these criteria.

Submission Guidelines: To be considered for the Leadership in Cardiovascular Medicine Award, applicants must adhere to the submission guidelines outlined on our official website. Submissions should include a detailed biography, an abstract of the candidate’s leadership initiatives, and supporting files showcasing the impact of their contributions.

Recognition: Recipients of the Leadership in Cardiovascular Medicine Award will receive public recognition for their outstanding leadership in cardiovascular health. This includes features in medical publications, acknowledgment at relevant events, and the opportunity to share insights with the community.

Community Impact: The Leadership in Cardiovascular Medicine Award emphasizes the importance of community impact. Successful candidates will demonstrate how their leadership initiatives have positively affected individuals and communities, contributing to the overall well-being of society.

Biography: Candidates are required to submit a comprehensive biography, highlighting their leadership journey, achievements, and dedication to advancing cardiovascular medicine. This allows the selection committee to gain a deeper understanding of the candidate’s background and contributions.

Abstract and Supporting Files: Applicants should provide a concise abstract summarizing their leadership initiatives and their significance in advancing cardiovascular medicine. Supporting files, such as research papers, presentations, or visual materials, should be included to provide a comprehensive overview of the candidate’s leadership impact.